TynanDx was born out of many years of experience developing products and bringing them to market. We truly believe that better clinical diagnostic data leads to the efficient delivery of health care.
Read more

  • The Value of Precision Medicine is Clear!

    There are now many studies that support the thesis that patients who receive a treatment matched to a tumor molecular profile have a longer progression free survival (PFS).  Von Hoff et al JCO 2010;28 4877-4883, Tsimberridou et al., Clin Cancer Res 2014;20 4827-4836, Schwaederle et al (Abstract 11097) presented at ASCO summarized the analysis of… Read more »

Key Success Factors for Diagnostic Development

TynanDx helps you focus on the issues that impact clinical diagnostic development and commercialization